Researchers from the Mitochondrial Medicine Program at Children's Hospital of Philadelphia (CHOP) have better characterized a ...

Canada’s pharmaceutical industry is undergoing a major transition towards personalized medicine, which customizes therapies ...

BioMarin's gene therapy pipeline has had setbacks, including a three-year delay in US approval of Roctavian and stalled development of PKU gene therapy BMN 307 as the Food and Drug Administration ...

Scientists at the Icahn School of Medicine at Mount Sinai and collaborators have identified novel genetic interactions that may contribute to congenital heart disease (CHD), a common birth defect.

Scientists have identified novel genetic interactions that may contribute to congenital heart disease (CHD), a common birth defect.

Highly valued economically, ecologically and culturally, the white oak (Quercus alba) is a keystone forest species and is one ...

Digital sequence information, or “DSI”, refers to the genetic information derived from biodiversity. Public and private databases – headquartered mainly in the global north – often source this genetic ...

Element Unveils AVITI24™ Innovation Roadmap Ahead of the Advances in Genome Biology and Technology (AGBT) 2025 Annual Meeting ...

When symptoms such as "noticing significant developmental delays in mobility, language, and social interaction since age two" are entered into a dialogue box, an AI large model can generate alerts ...

A study finds that lifestyle and environment influence health more than genetics. Smoking, income, and exercise shape disease risk.

According to analysts, this change implies how policymakers are now concerned about slowing growth and the US’s efforts to limit China’s technological development. Meeting with tech leaders such as ...

Ionis relies on upfront payments and licensing fees from partners, as well as Spinraza royalties, to drive revenue today, but its rapidly advancing portfolio should help diversify revenue. 2025 is ...